Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

Feb 20, 2007

29777_dirs_2007-02-20_3b9b750d-5871-4afd-83e8-7b01b7ab1656.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-02-16

Reporting Person: ASHLEY RICHARD W (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-16 Common shares without par value A 55200 $52.54 Acquired 156674 Direct
2007-02-16 Common shares without par value A 21000 $52.54 Acquired 177674 Direct
2007-02-17 Common shares without par value F 7233 $52.49 Disposed 170441 Direct
2007-02-18 Common shares without par value F 4011 $52.49 Disposed 166430 Direct

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.